# Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

> **NCT03821857** · PHASE4 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 614 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** 18-F-Flortaucipir

## Key facts

- **NCT ID:** NCT03821857
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-06-27
- **Primary completion:** 2030-05
- **Final completion:** 2030-05
- **Target enrollment:** 614 (ESTIMATED)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03821857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03821857, "Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03821857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*